Founded on Science.
Focused on Patients.

Discovering, Developing & Commercializing Targeted Small Molecule Drugs in Cancer

A Year of
Significant
Progress

Read Ron Squarer's
letter to shareholders

10K REPORT

Download

ANNUAL REPORT

Download